Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Diabetes MellitusType 1 DiabetesInsulin Pump
Interventions
DEVICE

t:slim insulin pump with predictive low glucose suspend

To assess the functionality of a predictive low glucose suspend (PLGS) system that uses Continuous Glucose Monitoring (CGM) values to suspend basal insulin delivery when hypoglycemia is predicted as well as resume basal insulin delivery once Continuous Glucose Monitoring (CGM) values begin to increase.

Trial Locations (2)

80045

Barbara Davis Center for Childhood Diabetes, Aurora

94304

Stanford University, Palo Alto

Sponsors
All Listed Sponsors
collaborator

Jaeb Center for Health Research

OTHER

lead

Tandem Diabetes Care, Inc.

INDUSTRY